Cognitive-Behavioral Therapy for Adolescent Body Dysmorphic Disorder: A Pilot Study |
| |
| Affiliation: | 1. The Institute of Psychiatry, Psychology and Neuroscience, King''s College London, 16 De Crespigny Park, London SE5 8AF, UK;2. Maudsley Hospital, South London and Maudsley NHS Foundation Trust, Denmark Hill, London SE5 8AZ, UK;1. Department of Psychosomatic Medicine and Psychotherapy, University Hospital of Erlangen, University of Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen, Germany;2. Department of Clinical Psychology and Psychotherapy, University of Wuppertal, Max-Horkheimer-Str. 20, 42097 Wuppertal, Germany;1. Department of Psychiatry, St Vincent''s Hospital, Melbourne, VIC, Australia;2. Department of Psychiatry, The University of Melbourne, Melbourne, VIC, Australia;3. Department of Mental Health, The Austin Hospital, Melbourne, VIC, Australia;4. Brain & Psychological Sciences Research Centre, Swinburne University of Technology, Melbourne, VIC, Australia;5. Monash Alfred Psychiatry Research Centre, Melbourne, VIC, Australia;6. Library Service, St Vincent''s Hospital, Melbourne, VIC, Australia;7. Faculty of Health Sciences, Australian Catholic University, Melbourne, VIC, Australia |
| |
| Abstract: | Body dysmorphic disorder (BDD) is a relatively common and severe disorder that typically onsets in adolescence, but often goes unrecognized. Despite BDD’s severity and early onset, treatment outcome research on adolescent BDD is scarce. Cognitive-behavioral therapy is the gold-standard psychosocial treatment for BDD in adults and has shown promise in adolescents. The current study examined the development and testing of a new CBT for adolescents with BDD. We tested feasibility, acceptability, and treatment outcome in a sample of 13 adolescents (mean age 15.23 years, range: 13–17) with primary BDD. Treatment was delivered in 12–22 weekly individual sessions. Standardized clinician ratings and self-report measures were used to assess BDD and related symptoms pre- and posttreatment and at 3- and 6-months follow-up. At posttreatment, BDD and related symptoms (e.g., insight, mood) were significantly improved. Scores on the Yale–Brown Obsessive Compulsive Scale for BDD indicated a 50% (intent-to-treat) and 68% (completer) improvement in BDD symptoms. Seventy-five percent of adolescents who started treatment and 100% of completers were considered treatment responders. Treatment gains were maintained at follow-up. High patient satisfaction ratings and patient feedback indicated that treatment was acceptable. This represents the largest study of a psychosocial treatment for adolescent BDD. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
